July 23rd 2013EP. 1: Episode 1 - Recognizing Rare Diseases in the United States
July 23rd 2013EP. 2: Episode 2 - How Advocacy and Policy Intertwine
July 23rd 2013EP. 3: Episode 3 - The Far-Reaching Burden of Rare Diseases
July 23rd 2013EP. 4: Episode 4 - A Clinical Overview of Hemophilia
July 23rd 2013EP. 5: Episode 5 - Current Therapeutic Strategies for Hemophilia
July 23rd 2013EP. 6: Episode 6 - Addressing the Gaps in Care for Hemophilia Patients
July 23rd 2013EP. 7: Episode 7 - Minimizing the Burden of SLE
July 23rd 2013EP. 8: Episode 8 - Long-Acting Agents and Considerations
July 23rd 2013EP. 9: Episode 9 - The Future Landscape for the Treatment of Hemophilia
July 23rd 2013EP. 10: Episode 10 - Treating Mild and Severe Hemophilia
July 23rd 2013EP. 11: Episode 11 - Minimizing the Burden of SLE
July 23rd 2013EP. 12: Episode 12 - Recognizing the Strengths and Weaknesses of Current Clinical Practice Guidelines
July 23rd 2013EP. 13: Episode 14 - Unmet Needs for Treatment of SLE
July 23rd 2013EP. 14: Episode 13 - Challenges of Measuring the Outcomes of SLE
July 23rd 2013EP. 15: Episode 16 - Factors Hindering Care for SLE Patients
July 23rd 2013EP. 16: Episode 17 - Future Outlook on the Orphan Drug Market
July 23rd 2013EP. 17: Episode 18 - The Role of Specialty Pharmacies in Rare Diseases
July 23rd 2013EP. 18: Episode 19 - The Future of SLE and Hemophilia
July 23rd 2013EP. 19: Episode 15 - SLE: Expectations As the Drug Market Evolves
